CANYON CAPITAL ADVISORS LLC - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 36 filers reported holding HORIZON PHARMA INVT LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CANYON CAPITAL ADVISORS LLC ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q1 2019$5,691,000
-84.0%
5,000,000
-86.0%
0.14%
-83.7%
Q4 2018$35,592,000
+28.5%
35,600,000
+29.5%
0.84%
+122.8%
Q3 2018$27,693,000
-3.5%
27,500,000
-8.3%
0.38%
+18.2%
Q2 2018$28,712,000
+16.0%
30,000,000
+11.1%
0.32%
+27.6%
Q1 2018$24,761,000
-0.5%
27,000,0000.0%0.25%
-30.4%
Q4 2017$24,895,000
+2.1%
27,000,0000.0%0.36%
-1.6%
Q3 2017$24,384,000
+4.8%
27,000,0000.0%0.36%
-5.2%
Q2 2017$23,271,00027,000,0000.38%
Other shareholders
HORIZON PHARMA INVT LTD shareholders Q1 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 90,100,000$83,284,0003.21%
Lion Point Capital, LP 16,000,000$14,560,0002.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 42,250,000$38,448,0002.11%
ADVENT CAPITAL MANAGEMENT /DE/ 52,956,000$48,618,0000.91%
LINDEN ADVISORS LP 25,106,000$22,975,0000.85%
Jabre Capital Partners S.A. 6,700,000$6,135,0000.73%
Nicholas Investment Partners, LP 11,085,000$10,087,0000.71%
AQR Arbitrage LLC 38,875,000$35,571,0000.40%
SSI INVESTMENT MANAGEMENT LLC 3,325,000$3,025,0000.28%
PALISADE CAPITAL MANAGEMENT, LP 6,278,000$5,766,0000.22%
View complete list of HORIZON PHARMA INVT LTD shareholders